Sahil Kirpekar - 01 Dec 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Business Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
01 Dec 2022
Transactions value $
$0
Form type
4
Filing time
02 Dec 2022, 15:20:18 UTC
Previous filing
02 Dec 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +750K $0.00 750K 01 Dec 2022 Common Shares 750K $3.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter.